CyGenica develops GEENIE, an engineered protein nanoneedle platform for non-viral intracellular delivery of therapeutic payloads
CyGenica develops GEENIE, an engineered protein nanoneedle platform for non-viral intracellular delivery of therapeutic payloads. Designed to bypass endosomal entrapment and deliver molecules directly into cells, the platform is being developed for nucleic acids, gene-editing components, proteins, peptides, antibiotics, and small molecules, with applications including cancer and rare diseases.